CDC briefing: Top officials talk up vaccine plans, focus on long-term care
By
Alicia Lasek
Oct 22, 2020
Federal health officials touted transparency and nationwide distribution plans while keeping their eye on Phase 1 vaccine recipients, including LTC residents and workers.
Alzheimer’s drug slows mental, functional decline in Eli Lilly trial
By
Alicia Lasek
Jan 12, 2021
Participants who took donanemab for 76 weeks showed 32% slower decline in thinking and daily function compared with those in a placebo group.
AMDA’s new COVID vaccine PowerPoint can help answer resident, staff concerns
By
Alicia Lasek
Dec 09, 2020
A toolkit created by industry clinicians aims to help long-term care operators address questions about getting vaccinated. A PowerPoint presentation is available to share with staff and residents.
COVID trial vaccines may be inadequate, some FDA advisors fear
By
Alicia Lasek
Oct 26, 2020
The current vaccine trials may be too focused on mild rather than severe disease, some advisors contend. But their arguments got pushback in a meeting streamed on the agency’s YouTube channel.
Drug that targets Alzheimer’s inflammation approved for trial by FDA
By
Alicia Lasek
Feb 09, 2021
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.
Seniors are absent — but necessary — in COVID-19 vaccine trials, experts say
By
Alicia Lasek
Sep 29, 2020
With older adults frequently excluded in COVID-19 clinical trials, investigators are concerned that they will ultimately be denied treatments and vaccines due to safety concerns.
COVID vaccine protects elderly; delivery program has buy-in from nearly all U.S. nursing homes
By
Alicia Lasek
Nov 19, 2020
Fully 99% of skilled nursing facilities nationwide have signed on with the federal Pharmacy Partnership for Long-Term Care Program vaccine delivery initiative, HHS says. The news arrived just as Pfizer...
LTC research hub to bring clinical trials to rural residents
By
Alicia Lasek
Sep 16, 2022
Nursing home operator Principle LTC and Care Access, a research organization, have launched a new research hub in Raleigh, NC, to provide rural residents access to clinical trials.
FDA approves first drug to slow Alzheimer’s in controversial decision
By
Alicia Lasek
Jun 07, 2021
The evidence convincingly shows that aducanumab (Aduhelm) removes beta amyloid — a hallmark of Alzheimer’s — from the brain, slowing the disease’s progression and giving patients and families much-needed...